Oakwell Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$590K Sell
641
-3
-0.5% -$3.04K 0.11% 51
2025
Q4
$692K Buy
644
+56
+10% +$53.5K 0.13% 53
2025
Q3
$449K Sell
588
-28
-5% -$20.8K 0.09% 59
2025
Q2
$480K Sell
616
-9
-1% -$6.99K 0.11% 52
2025
Q1
$516K Buy
625
+158
+34% +$131K 0.14% 46
2024
Q4
$361K Hold
467
0.1% 51
2024
Q3
$414K Hold
467
0.12% 48
2024
Q2
$423K Buy
467
+26
+6% +$20.8K 0.12% 49
2024
Q1
$343K Buy
441
+10
+2% +$7.12K 0.1% 49
2023
Q4
$251K Buy
+431
New +$252K 0.09% 54

Other funds holding LLY

Oakwell Private Wealth Management's LLY Position: Q1 2026 in Review

Oakwell Private Wealth Management reduced its Eli Lilly (LLY) stake by 0.47% in Q1 2026, selling an estimated $3.04K and leaving 641 shares worth $590K. The position accounts for 0.11% of the portfolio, ranked #51.

Oakwell Private Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $692K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Oakwell Private Wealth Management held 641 shares of Eli Lilly worth $590K as of Q1 2026.
  • Oakwell Private Wealth Management sold 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
  • Eli Lilly made up 0.11% of Oakwell Private Wealth Management's portfolio in Q1 2026, its #51 holding.
  • Oakwell Private Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Oakwell Private Wealth Management's Eli Lilly position peaked at $692K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Oakwell Private Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.